DIVI S LABORATORIES LTD vs KRSNAA DIAGNOSTICS LTD

A side-by-side comparison of DIVI S LABORATORIES LTD (DIVISLAB) and KRSNAA DIAGNOSTICS LTD (KRSNAA) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.

The verdict

On the numbers, DIVI S LABORATORIES LTD leads DIVISLAB vs KRSNAA on 9 of 14 metrics. See the breakdown below — the right pick still depends on your goals (value vs growth, risk appetite).

  • Valuation13
  • Profitability40
  • Growth02
  • Size & financial health40
ValueReturnsMarginGrowthScaleLow debt

Each axis shows this group's split of that metric, scaled so the leader sits at the edge. Relative to each other, not an absolute score.

Valuation

KRSNAA takes 3/4

How expensive each stock is relative to its earnings and book value. Lower usually means cheaper.

94.49
P/E ratio
21.80
10.62
P/B ratio
1.85
0.33%
Dividend yield
0.36%
₹96.73
EPS
₹25.65

Profitability

DIVISLAB takes 4/4

How efficiently each company turns capital and sales into profit. Higher is better.

16.50%
Return on equity
9.29%
22.00%
Return on capital
13.00%
33.00%
EBITDA margin
29.00%
24.32%
Net margin
12.17%

Growth

KRSNAA takes 2/2

Three-year compounded growth. Faster-growing businesses can justify a higher valuation.

10.78%
Revenue CAGR (3Y)
14.20%
12.10%
Profit CAGR (3Y)
17.19%

Size & financial health

DIVISLAB takes 4/4

Scale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.

₹2.43L Cr
Market cap
₹1,822 Cr
₹10,560 Cr
Revenue
₹682 Cr
₹2,568 Cr
Net profit
₹83 Cr
0.00
Debt / equity
0.23
DIVI S LABORATORIES LTD
  • + ["Company is almost debt free.", "Company has been maintaining a healthy dividend payout of 39.0%"]
  • ["Stock is trading at 14.6 times its book value", "The company has delivered a poor sales growth of 8.67% over past five years."]
KRSNAA DIAGNOSTICS LTD
  • + ["Company's median sales growth is 31.8% of last 10 years"]
  • ["The company has delivered a poor sales growth of 11.8% over past five years.", "Promoter holding is low: 27.1%", "Company has a low return on equity of 9.34% over last 3 years.", "Company has high debtors of 163 days.", "Working capital days have increased from 25.4 days to 65.9 days"]
DIVI S LABORATORIES LTD full analysis KRSNAA DIAGNOSTICS LTD full analysis

This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.

DIVISLAB vs KRSNAA: Share Price, Valuation & Which to Buy | DocStoX